Clinical Scorecard: Adherence to Treatment in Chronic Uveitis: Insights from the MARS-5 Assessment
At a Glance
Category
Detail
Condition
Key Mechanisms
Inflammation of the uveal tract, potentially caused by infectious agents (e.g., herpes, syphilis) or autoimmune processes (e.g., sarcoidosis, Behçet's disease).
Target Population
Care Setting
Key Highlights
The study utilized a cross-sectional design with 114 adult patients to assess adherence.
Guideline-Based Recommendations
Diagnosis
Management
Utilize corticosteroids, immunomodulatory therapies (e.g., methotrexate, azathioprine), and biologic agents (e.g., adalimumab, infliximab) for treatment.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Adults with chronic uveitis requiring long-term treatment.
Effective management relies on consistent medication adherence.
Clinical Best Practices
Educate patients on the importance of adherence to treatment.
Identify and address barriers to medication adherence.
Utilize validated assessment tools to monitor adherence.
Schedule regular follow-ups to assess and encourage adherence.
During the Glaucoma Group Therapy session at AAO 2025, moderated by Mary Qiu, MD, and Aakriti Garg Shukla, MD, MSc, presenters discussed challenging cases.
